Brain Pacemaker Market Size is Expected to Reach USD 5.97 Billion by 2035; Industry Growth is Propelling Owing to Surging Incidence of Neurological Disorders | SNS Insider

Brand Post
By Globenewswire

The U.S. Brain Pacemaker Market was USD 1.38 Billion in 2025, expected to reach USD 2.13 Billion by 2035 owing to Parkinson’s disease prevalence

Austin, May 07, 2026 (GLOBE NEWSWIRE) — According to SNS Insider, The Brain Pacemaker Market size was valued at USD 3.77 Billion in 2025 and is projected to reach USD 5.97 Billion by 2035, growing at a CAGR of 4.70% during the forecast period of 2026–2035.

Growing incidence of neurological disorders, growing demand for personalized neurostimulation treatments and its higher adoption in the hospitals, neurology clinics and homecare settings are some of the key market growth drivers.

Brain Pacemaker Market Report Scope & Overview

Get a Sample Report of Brain Pacemaker Market Forecast @ https://www.snsinsider.com/sample-request/8533

Brain Pacemaker Market Size and Forecast:

  • Market Size in 2025: USD 3.77 Billion
  • Market Size by 2035: USD 5.97 Billion
  • CAGR: 4.70% from 2026 to 2035
  • Base Year: 2025
  • Forecast Period: 2026–2035
  • Historical Data: 2022–2024

The U.S. Brain Pacemaker Market was USD 1.38 Billion in 2025, expected to reach USD 2.13 Billion by 2035 at a CAGR of 4.42%. 

The U.S. market growth is driven by Parkinson’s disease prevalence, epilepsy cases, dual-/multi-channel adoption, minimally invasive procedures, and advanced neurostimulation investments.

Increasing Parkinson’s Disease and Epilepsy Cases to Augment Market Expansion Globally

The incidence of neurological disorders and the use of improved neurostimulation are driving the steady growth of the worldwide brain pacemaker market. By 2025, over 92,000 brain pacemakers had been implanted worldwide, with 38% of those instances being for Parkinson’s disease. 49% of new devices were rechargeable implanted systems, indicating a patient desire for long-term treatments. About 65% of the procedures covered in the surgical treatment procedures market are handled by hospitals and neurology centers, supporting global expansion.

Brain Pacemaker Market Segmentation Analysis:

By Power Source

Rechargeable Systems held the largest share of 59.26% in 2025 as they last and save fewer replacements. Wireless Power Transfer Systems are anticipated to grow at the fastest CAGR of 6.12% as they continue to be relevant for classical neuromodulation and a variety of patient usages during the forecast period.

By Device Type

Dual-Channel Brain Pacemakers held the largest market share of 34.72% in 2025 as it had more than 42,300 global implantations in 2025 for various symptoms of Parkinson’s disease. Multi-Channel Brain Pacemakers are expected to grow at the highest CAGR of 6.47% with 29,800 implants in 2025 and a projected number of 54,200 by 2035 for advanced neuromodulation abilities.

By Implantation Type

Invasive Procedures accounted for the largest market share of 50.28% in 2025 as it is mainly performed for PD and epilepsy. Minimally Invasive Procedures are projected to grow at the fastest CAGR of 5.53% due to an anticipated volume of 58,900 in year 2035 through reduced recovery times and patient choice.

By Indication

Parkinson’s Disease contributed the highest market share of 39.81% in 2025 due to an increasing incidence of movement disorders. Epilepsy is forecasted to expand at the fastest CAGR of 5.04% due to essential tremor and other neurological conditions together accounted for 16,500 procedures.

By End User

Hospitals accounted for the largest share of 44.63% in 2025 due to the presence of surgical infrastructure globally. Specialty Neurology Clinics are expected to grow at the fastest CAGR of 5.79% as specialty neurology practices conducted 26,800 procedures and grew significantly from minimally invasive methods and personalized care.

Related Posts

Chennai Water Purifier Rentals Rise as ₹15,000 Purchase Costs and ₹4,000 AMC Push Households Toward ₹500/Month Plans Like Rentomojo

Trident Announces Hearings Panel Date

E-Power Subsidiary Awarded Key Patent for Advanced Silicon-Carbon Composite Materials, Strengthening Solid-State Battery Innovation

For an In-Depth Strategic Briefing with Our Research Team, Connect Now @ https://www.snsinsider.com/request-analyst/8533

Brain Pacemaker Market Regional Insights:

North America dominates the Brain Pacemaker market with a 44.87% share in 2025, driven by advanced neurology infrastructure and high prevalence of Parkinson’s disease and epilepsy. In 2025, more than 42,300 brain pacemaker surgeries were carried out in hospitals and specialized neurology departments.

The Asia-Pacific Brain Pacemaker market is projected to grow at a CAGR of 6.14% during 2026–2035, making it the fastest-growing region globally. More than 12,800 brain pacemakers were implanted in hospitals and specialty neurology clinics and outpatient centers in 2025.

Major Players Analysis Listed in the Brain Pacemaker Market Report:

  • Medtronic
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Aleva Neurotherapeutics
  • NeuroPace, Inc.
  • Renishaw plc
  • Beijing PINS Medical Co., Ltd.
  • SceneRay Co., Ltd.
  • LivaNova PLC
  • BrainsWay Ltd.
  • Functional Neuromodulation Ltd.
  • NeuroSigma
  • Synapse Biomedical Inc.
  • Synteract
  • Alpha Omega Engineering Ltd.
  • Newronika S.p.A.
  • Soterix Medical
  • AlphaDBS Solutions (Deep Brain Innovations)
  • Neuronetics, Inc.
  • Fisher Wallace Laboratories, Inc.

Brain Pacemaker Market Recent Developments:

  • In February 2025, Medtronic received FDA approval for its BrainSense Adaptive DBS system, enhancing therapy for Parkinson’s patients globally.
  • In March 2025, Boston Scientific updated its Vercise Genus DBS System with MR-conditional IPGs, supporting precise targeting and personalized therapy.

Purchase Single User PDF of Brain Pacemaker Market Report @ https://www.snsinsider.com/checkout/8533

Exclusive Sections of the Report (The USPs):

  • CLINICAL ADOPTION & PROCEDURE VOLUME ANALYSIS – helps you understand DBS implantation trends, patient adoption across neurological disorders, and procedure penetration across hospitals and specialty clinics.
  • REGULATORY & REIMBURSEMENT COMPLIANCE INSIGHTS – helps you evaluate approval frameworks, clinical safety requirements, reimbursement policies, and compliance strategies for implantable neurostimulation devices.
  • NEUROMODULATION TECHNOLOGY & INNOVATION METRICS – helps you track advancements in closed-loop stimulation systems, AI-enabled brain monitoring, wireless implants, and rechargeable neurostimulation technologies.
  • HEALTHCARE ACCESSIBILITY & INFRASTRUCTURE ANALYSIS – helps you assess availability of neurosurgical centers, DBS specialists, patient affordability, insurance coverage, and regional accessibility gaps.
  • INVESTMENT & STRATEGIC COLLABORATION LANDSCAPE – helps you identify venture capital activity, strategic partnerships, M&A trends, and expanding research collaborations in neurotechnology markets.
  • COMPETITIVE LANDSCAPE & MARKET POSITIONING – helps you gauge the competitive strength of leading brain pacemaker manufacturers based on innovation capabilities, product portfolios, clinical advancements, and global expansion strategies.

Brain Pacemaker Market Report Scope

Report Attributes Details
Market Size in 2025 USD 3.77 Billion 
Market Size by 2035 USD 5.97 Billion 
CAGR CAGR of 4.70% From 2026 to 2035
Base Year 2025
Forecast Period 2026-2035
Historical Data 2022-2024
Key Segments • By Device Type (Single-Channel Brain Pacemaker, Dual-Channel Brain Pacemaker, Multi-Channel Brain Pacemaker, Next-Generation Neurostimulator Systems)
• By Implantation Type (Invasive, Minimally Invasive, Non-Invasive)
• By Indication (Parkinson’s Disease, Epilepsy, Depression, Essential Tremor, Obsessive-Compulsive Disorder, Chronic Pain, Other Neurological Disorders)
• By Power Source (Rechargeable Implantable, Non-Rechargeable Implantable)
• By End User (Hospitals, Neurology Clinics / Specialty Clinics, Home Care Settings, Rehabilitation Centers, Academic & Research Institutes)
Regional Analysis/Coverage North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America).

Rising Demand for Brain Pacemaker Market Data, Our Full Report Trend Analysis @ https://www.snsinsider.com/reports/brain-pacemaker-market-8533

Other Trending Related Report:

Neuropathic Pain Market

Brain Ischemia Market

Brain Tumor Treatment Market

Traumatic Brain Injury Biomarkers Market

Wireless Brain Sensors Market

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Data Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaEveningPost.com takes no editorial responsibility for the same.